10X Genomics (TXG) PT Lowered to $14 at Goldman Sachs
Tweet
Share
E-mailGet Alerts TXG Hot Sheet
Price: $58.15 --0%
Rating Summary:
7 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 11
Rating Summary:
7 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 11
Join SI Premium – FREE
Goldman Sachs analyst Matthew Sykes lowered the price target on 10X Genomics (NASDAQ: TXG) to $14.00 (from $16.00) while maintaining a Sell rating.
You May Also Be Interested In
- Deere (DE) PT Lowered to $570 at JPMorgan Ahead of Earnings
- Johnson Controls (JCI) PT Raised to $190 at Bernstein SocGen Group
- Target (TGT) PT Raised to $146 at Piper Sandler
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
